YI Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

7.089

Open

6.755

VWAP

6.77

Vol

6.79K

Mkt Cap

92.95M

Low

6.480

Amount

46.00K

EV/EBITDA(TTM)

581.88

Total Shares

--

EV

170.00M

EV/OCF(TTM)

4.65

P/S(TTM)

0.03

111 Inc is an investment holding company primarily engaged in the operation of integrated online and offline healthcare platform. The Company mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The Company also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The Company mainly conducts its business in the domestic market.

Show More

Events Timeline

(ET)

2026-01-30

14:50:00

111 Inc ADR Trading Halted Due to Volatility Trading Pause

2025-02-11 (ET)

2025-02-11

07:01:56

111, Inc. regains Nasdaq compliance

2025-01-08 (ET)

2025-01-08

04:08:32

111, Inc. announces one-for-twenty ADS ratio change

2024-10-10 (ET)

2024-10-10

06:12:51

111, Inc. announces South, Central China fulfillment centers begin operations

2024-09-27 (ET)

2024-09-27

17:28:47

111, Inc. discloses Nasdaq listing deficiency notice

2024-08-29 (ET)

2024-08-29

05:17:09

111, Inc. reports Q2 EPS (RMB 0.16) vs. (RMB 0.68) last year

News

NASDAQ.COM

04-09NASDAQ.COM

111, Inc. Reports Narrower Q4 Net Loss Driven by Lower Expenses

PRnewswire

04-09PRnewswire

111, Inc. Releases Financial Results for Fiscal Year 2025

seekingalpha

04-09seekingalpha

111 Reports Q4 Financial Results

Newsfilter

04-09Newsfilter

111 Inc. Reports Significant Financial Improvement for FY 2025

PRnewswire

2025-12-17PRnewswire

111, Inc. Achieves Non-GAAP Profitability for Third Consecutive Quarter

Newsfilter

2025-12-17Newsfilter

111, Inc. Transitions to Asset-Light Model, Achieves Non-GAAP Profitability for Three Consecutive Quarters

Valuation Metrics

The current forward P/E ratio for 111 Inc (YI.O) is 0.00, compared to its 5-year average forward P/E of 12.19. For a more detailed relative valuation and DCF analysis to assess 111 Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

N/A

5Y Average PE

12.19

Current PE

0.00

Overvalued PE

61.29

Undervalued PE

-36.91

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

N/A

5Y Average EV/EBITDA

1.34

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

24.73

Undervalued EV/EBITDA

-22.05

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

5Y Average PS

0.09

Current PS

0.04

Overvalued PS

0.17

Undervalued PS

0.02

Financials

AI Analysis

Annual

Quarterly

Whales Holding YI

Trading Trends

People Also Watch

Frequently Asked Questions

What is 111 Inc (YI) stock price today?

The current price of YI is 6.75 USD — it has decreased -1.75

What is 111 Inc (YI)'s business?

111 Inc is an investment holding company primarily engaged in the operation of integrated online and offline healthcare platform. The Company mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The Company also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The Company mainly conducts its business in the domestic market.

What is the price predicton of YI Stock?

Wall Street analysts forecast YI stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for YI is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is 111 Inc (YI)'s revenue for the last quarter?

111 Inc revenue for the last quarter amounts to 3.85B USD, decreased -6.35

What is 111 Inc (YI)'s earnings per share (EPS) for the last quarter?

111 Inc. EPS for the last quarter amounts to -1.15 USD, decreased -90.71

How many employees does 111 Inc (YI). have?

111 Inc (YI) has 1238 emplpoyees as of April 23 2026.

What is 111 Inc (YI) market cap?

Today YI has the market capitalization of 92.95M USD.